Dr. Supratik Bhattacharyya

Dr. Supratik Bhattacharyya, a distinguished endocrinologist and diabetologist, has an illustrious career marked by extensive qualifications, numerous accolades, and significant contributions to the field of endocrinology, diabetes, and obesity management. His academic credentials are impressive, including an MBBS with distinction, MRCP(UK), MD, and MS in Endocrinology & Diabetes from London, among other notable certifications. Dr. Bhattacharyya is a Fellow of the Royal College of Physicians (Edinburgh), the American Association of Clinical Endocrinology (AACE), the American College of Physicians (ACP), the Indian Society of Hypertension, RSSDI, and Diabetes India. He has also completed Executive Management Programs for Healthcare professionals from Darden, University of Virginia, and IIM Ahmedabad. He is the foremost Endocrinologist and Diabetologist in Kolkata.

Currently, Dr. Bhattacharyya serves as the Director of a Diabetes & Endocrine Centre and is a consultant at Manipal Hospitals Broadway. With over 11 years of specialized practice in diabetes, obesity, and endocrinology, and 17 years of overall clinical experience, he has made a profound impact on patient care and medical research.

Dr. Bhattacharyya’s research contributions are significant, having presented high-quality medical research at esteemed international platforms such as the American Diabetes Association, Endocrine Society (USA), AACE, International Diabetes Federation, ATTD (Berlin), and the European Association for the Study of Diabetes. His work has also been recognized at national forums like RSSDI and ESI, garnering global appreciation and citations.

As the Director of SKN Diabetes & Endocrine Centre, Dr. Bhattacharyya oversees a Centre of Excellence that caters to the suburban and rural populations around Kolkata. The centre offers holistic management of diabetes, its complications, and other endocrine disorders like thyroid diseases. It is equipped with facilities for screening diabetes-related complications and conducts Phase 3 and Phase 4 clinical studies regularly. The centre also focuses on patient education, organizing monthly programs to raise awareness about diabetes, thyroid issues, obesity, and other endocrine disorders. Additionally, SKN Diabetes conducts campaigns and walkathons to promote awareness of these conditions. The centre’s accreditation by The Endocrine Society (USA) underscores its commitment to high standards of care and research.

Dr. Bhattacharyya’s excellence in the medical field has been recognized through various awards and honours. In 2022, he received the Inspiring Endocrinologist & Diabetologist of India Award from the Economic Times. He was also honoured with the International Rising Star Award 2021 by the International Diabetes Center, Park Nicollet, and the Rising Star Award 2021 in Endocrinology & Diabetes by the Indian Academy of Diabetes. His innovative contributions during challenging times earned him the RSSDI 2020 award for Best Innovation in Diabetes Care. Other accolades include the Best Oral Paper Presentation at the ASIA Pacific Congress of Hypertension 2021, the ACP Governor’s Recognition Award 2021, and the Best National Diabetes Awareness Initiative Award 2016 by Diabetes India.

In academia, Dr. Bhattacharyya has held prestigious positions such as Assistant Professor in Medical Education Services, WB, and visiting lecturer in Endocrinology & Diabetes at the University of South Wales, UK. He is a regular speaker, moderator, and chairperson at national and international conferences, CMEs, and webinars. His expertise in obesity management is highlighted by his SCOPE certification and preceptorship at Guys & St. Thomas (London), NHS, UK. He has been involved in multiple Phase 3 and Phase 4 studies as a principal investigator or co-investigator, including the recently published international DIARAMADAN study.

Dr. Bhattacharyya holds several organizational positions, demonstrating his leadership and influence in the field. He is the Founder President and Secretary General of the Association of Metabolic, Obesity Physicians and Clinical Endocrinologists (AMOCE). He is also part of the RSSDI Defeat Diabetes Taskforce and has served as Organizing Secretary of the AMOCEiCON Conference 2024 and Scientific Secretary of the ACP India Annual Conference 2021. He has played pivotal roles in organizing numerous conferences and symposiums, such as the National SGLT2i PLUS symposium, ACP IM 2021, Diabetes India 2021, DiaVcon 2020, and the International Incretin Summit 2020.

Dr. Bhattacharyya’s publication record is extensive, with over 30 international publications as the first or corresponding author. Some notable publications include studies on Semaglutide Oral in Indian T2DM Patients, the efficacy and safety of Liraglutide in Indian adolescents with T2DM and obesity, and the real-world effectiveness of Dulaglutide monotherapy in obese Indian adults with prediabetes. His research also covers the efficacy and safety of Empagliflozin and Linagliptin in non-hospitalized COVID-19-positive patients with T2DM and the impact of Saroglitazar on diabetic dyslipidemia.

As an international editor for the Bangladesh Journal of Endocrinology and Metabolism and a reviewer for the Endocrine Practice Journal of AACE, Dr. Bhattacharyya continues to contribute to the scientific community. He has also authored several book chapters, including those on therapeutic options for elderly patients with diabetes and the DCCT & UKPDS.

Dr. Bhattacharyya is a sought-after speaker, having been invited to numerous national and international conferences. His presentations at events such as the RSSDI Research Retreat, International Diabetes Summit, END DIALOGUE, DIABETES INDIA, and Dr. Mohan’s International Diabetes Update highlight his expertise and influence in the field.

In addition to his clinical and academic roles, Dr. Bhattacharyya is actively involved in various advisory boards. His insights have been sought in meetings focused on topics such as the therapeutic positioning of diabetes medications, clinical positioning of different compositions of Vildagliptin, and the role of Remogliflozin in uncontrolled diabetes patients. He has participated in advisory meetings on the clinical implications and roles of Metformin SR+Vildagliptin, the placement of antihypertensives, and the positioning of novel SGLT2 inhibitors.

Dr. Supratik Bhattacharyya’s dedication to his field is evident through his extensive clinical practice, groundbreaking research, and commitment to patient education and advocacy. His leadership roles in various organizations and contributions to medical literature and conferences underscore his influence and expertise in endocrinology, diabetes, and obesity management. His ongoing efforts continue to impact patient care, medical research, and education, solidifying his reputation as a leading figure in his speciality.

Dr. Supratik Bhattacharyya, a distinguished endocrinologist and diabetologist, has an illustrious career marked by extensive qualifications, numerous accolades, and significant contributions to the field of endocrinology, diabetes, and obesity management. His academic credentials are impressive, including an MBBS with distinction, MRCP(UK), MD, and MS in Endocrinology & Diabetes from London, among other notable certifications. Dr. Bhattacharyya is a Fellow of the Royal College of Physicians (Edinburgh), the American Association of Clinical Endocrinology (AACE), the American College of Physicians (ACP), the Indian Society of Hypertension, RSSDI, and Diabetes India. He has also completed Executive Management Programs for Healthcare professionals from Darden, University of Virginia, and IIM Ahmedabad. He is the foremost Endocrinologist and Diabetologist in Kolkata.

Currently, Dr. Bhattacharyya serves as the Director of a Diabetes & Endocrine Centre and is a consultant at Manipal Hospitals Broadway. With over 11 years of specialized practice in diabetes, obesity, and endocrinology, and 17 years of overall clinical experience, he has made a profound impact on patient care and medical research.

Dr. Bhattacharyya’s research contributions are significant, having presented high-quality medical research at esteemed international platforms such as the American Diabetes Association, Endocrine Society (USA), AACE, International Diabetes Federation, ATTD (Berlin), and the European Association for the Study of Diabetes. His work has also been recognized at national forums like RSSDI and ESI, garnering global appreciation and citations.

As the Director of SKN Diabetes & Endocrine Centre, Dr. Bhattacharyya oversees a Centre of Excellence that caters to the suburban and rural populations around Kolkata. The centre offers holistic management of diabetes, its complications, and other endocrine disorders like thyroid diseases. It is equipped with facilities for screening diabetes-related complications and conducts Phase 3 and Phase 4 clinical studies regularly. The centre also focuses on patient education, organizing monthly programs to raise awareness about diabetes, thyroid issues, obesity, and other endocrine disorders. Additionally, SKN Diabetes conducts campaigns and walkathons to promote awareness of these conditions. The centre’s accreditation by The Endocrine Society (USA) underscores its commitment to high standards of care and research.

Dr. Bhattacharyya’s excellence in the medical field has been recognized through various awards and honours. In 2022, he received the Inspiring Endocrinologist & Diabetologist of India Award from the Economic Times. He was also honoured with the International Rising Star Award 2021 by the International Diabetes Center, Park Nicollet, and the Rising Star Award 2021 in Endocrinology & Diabetes by the Indian Academy of Diabetes. His innovative contributions during challenging times earned him the RSSDI 2020 award for Best Innovation in Diabetes Care. Other accolades include the Best Oral Paper Presentation at the ASIA Pacific Congress of Hypertension 2021, the ACP Governor’s Recognition Award 2021, and the Best National Diabetes Awareness Initiative Award 2016 by Diabetes India.

In academia, Dr. Bhattacharyya has held prestigious positions such as Assistant Professor in Medical Education Services, WB, and visiting lecturer in Endocrinology & Diabetes at the University of South Wales, UK. He is a regular speaker, moderator, and chairperson at national and international conferences, CMEs, and webinars. His expertise in obesity management is highlighted by his SCOPE certification and preceptorship at Guys & St. Thomas (London), NHS, UK. He has been involved in multiple Phase 3 and Phase 4 studies as a principal investigator or co-investigator, including the recently published international DIARAMADAN study.

Dr. Bhattacharyya holds several organizational positions, demonstrating his leadership and influence in the field. He is the Founder President and Secretary General of the Association of Metabolic, Obesity Physicians and Clinical Endocrinologists (AMOCE). He is also part of the RSSDI Defeat Diabetes Taskforce and has served as Organizing Secretary of the AMOCEiCON Conference 2024 and Scientific Secretary of the ACP India Annual Conference 2021. He has played pivotal roles in organizing numerous conferences and symposiums, such as the National SGLT2i PLUS symposium, ACP IM 2021, Diabetes India 2021, DiaVcon 2020, and the International Incretin Summit 2020.

Dr. Bhattacharyya’s publication record is extensive, with over 30 international publications as the first or corresponding author. Some notable publications include studies on Semaglutide Oral in Indian T2DM Patients, the efficacy and safety of Liraglutide in Indian adolescents with T2DM and obesity, and the real-world effectiveness of Dulaglutide monotherapy in obese Indian adults with prediabetes. His research also covers the efficacy and safety of Empagliflozin and Linagliptin in non-hospitalized COVID-19-positive patients with T2DM and the impact of Saroglitazar on diabetic dyslipidemia.

As an international editor for the Bangladesh Journal of Endocrinology and Metabolism and a reviewer for the Endocrine Practice Journal of AACE, Dr. Bhattacharyya continues to contribute to the scientific community. He has also authored several book chapters, including those on therapeutic options for elderly patients with diabetes and the DCCT & UKPDS.

Dr. Bhattacharyya is a sought-after speaker, having been invited to numerous national and international conferences. His presentations at events such as the RSSDI Research Retreat, International Diabetes Summit, END DIALOGUE, DIABETES INDIA, and Dr. Mohan’s International Diabetes Update highlight his expertise and influence in the field.

In addition to his clinical and academic roles, Dr. Bhattacharyya is actively involved in various advisory boards. His insights have been sought in meetings focused on topics such as the therapeutic positioning of diabetes medications, clinical positioning of different compositions of Vildagliptin, and the role of Remogliflozin in uncontrolled diabetes patients. He has participated in advisory meetings on the clinical implications and roles of Metformin SR+Vildagliptin, the placement of antihypertensives, and the positioning of novel SGLT2 inhibitors.

Dr. Supratik Bhattacharyya’s dedication to his field is evident through his extensive clinical practice, groundbreaking research, and commitment to patient education and advocacy. His leadership roles in various organizations and contributions to medical literature and conferences underscore his influence and expertise in endocrinology, diabetes, and obesity management. His ongoing efforts continue to impact patient care, medical research, and education, solidifying his reputation as a leading figure in his speciality.

Dr. Supratik Bhattacharyya, a distinguished endocrinologist and diabetologist, has an illustrious career marked by extensive qualifications, numerous accolades, and significant contributions to the field of endocrinology, diabetes, and obesity management. His academic credentials are impressive, including an MBBS with distinction, MRCP(UK), MD, and MS in Endocrinology & Diabetes from London, among other notable certifications. Dr. Bhattacharyya is a Fellow of the Royal College of Physicians (Edinburgh), the American Association of Clinical Endocrinology (AACE), the American College of Physicians (ACP), the Indian Society of Hypertension, RSSDI, and Diabetes India. He has also completed Executive Management Programs for Healthcare professionals from Darden, University of Virginia, and IIM Ahmedabad. He is the foremost Endocrinologist and Diabetologist in Kolkata.

Currently, Dr. Bhattacharyya serves as the Director of a Diabetes & Endocrine Centre and is a consultant at Manipal Hospitals Broadway. With over 11 years of specialized practice in diabetes, obesity, and endocrinology, and 17 years of overall clinical experience, he has made a profound impact on patient care and medical research.

Dr. Bhattacharyya’s research contributions are significant, having presented high-quality medical research at esteemed international platforms such as the American Diabetes Association, Endocrine Society (USA), AACE, International Diabetes Federation, ATTD (Berlin), and the European Association for the Study of Diabetes. His work has also been recognized at national forums like RSSDI and ESI, garnering global appreciation and citations.

As the Director of SKN Diabetes & Endocrine Centre, Dr. Bhattacharyya oversees a Centre of Excellence that caters to the suburban and rural populations around Kolkata. The centre offers holistic management of diabetes, its complications, and other endocrine disorders like thyroid diseases. It is equipped with facilities for screening diabetes-related complications and conducts Phase 3 and Phase 4 clinical studies regularly. The centre also focuses on patient education, organizing monthly programs to raise awareness about diabetes, thyroid issues, obesity, and other endocrine disorders. Additionally, SKN Diabetes conducts campaigns and walkathons to promote awareness of these conditions. The centre’s accreditation by The Endocrine Society (USA) underscores its commitment to high standards of care and research.

Dr. Bhattacharyya’s excellence in the medical field has been recognized through various awards and honours. In 2022, he received the Inspiring Endocrinologist & Diabetologist of India Award from the Economic Times. He was also honoured with the International Rising Star Award 2021 by the International Diabetes Center, Park Nicollet, and the Rising Star Award 2021 in Endocrinology & Diabetes by the Indian Academy of Diabetes. His innovative contributions during challenging times earned him the RSSDI 2020 award for Best Innovation in Diabetes Care. Other accolades include the Best Oral Paper Presentation at the ASIA Pacific Congress of Hypertension 2021, the ACP Governor’s Recognition Award 2021, and the Best National Diabetes Awareness Initiative Award 2016 by Diabetes India.

In academia, Dr. Bhattacharyya has held prestigious positions such as Assistant Professor in Medical Education Services, WB, and visiting lecturer in Endocrinology & Diabetes at the University of South Wales, UK. He is a regular speaker, moderator, and chairperson at national and international conferences, CMEs, and webinars. His expertise in obesity management is highlighted by his SCOPE certification and preceptorship at Guys & St. Thomas (London), NHS, UK. He has been involved in multiple Phase 3 and Phase 4 studies as a principal investigator or co-investigator, including the recently published international DIARAMADAN study.

Dr. Bhattacharyya holds several organizational positions, demonstrating his leadership and influence in the field. He is the Founder President and Secretary General of the Association of Metabolic, Obesity Physicians and Clinical Endocrinologists (AMOCE). He is also part of the RSSDI Defeat Diabetes Taskforce and has served as Organizing Secretary of the AMOCEiCON Conference 2024 and Scientific Secretary of the ACP India Annual Conference 2021. He has played pivotal roles in organizing numerous conferences and symposiums, such as the National SGLT2i PLUS symposium, ACP IM 2021, Diabetes India 2021, DiaVcon 2020, and the International Incretin Summit 2020.

Dr. Bhattacharyya’s publication record is extensive, with over 30 international publications as the first or corresponding author. Some notable publications include studies on Semaglutide Oral in Indian T2DM Patients, the efficacy and safety of Liraglutide in Indian adolescents with T2DM and obesity, and the real-world effectiveness of Dulaglutide monotherapy in obese Indian adults with prediabetes. His research also covers the efficacy and safety of Empagliflozin and Linagliptin in non-hospitalized COVID-19-positive patients with T2DM and the impact of Saroglitazar on diabetic dyslipidemia.

As an international editor for the Bangladesh Journal of Endocrinology and Metabolism and a reviewer for the Endocrine Practice Journal of AACE, Dr. Bhattacharyya continues to contribute to the scientific community. He has also authored several book chapters, including those on therapeutic options for elderly patients with diabetes and the DCCT & UKPDS.

Dr. Bhattacharyya is a sought-after speaker, having been invited to numerous national and international conferences. His presentations at events such as the RSSDI Research Retreat, International Diabetes Summit, END DIALOGUE, DIABETES INDIA, and Dr. Mohan’s International Diabetes Update highlight his expertise and influence in the field.

In addition to his clinical and academic roles, Dr. Bhattacharyya is actively involved in various advisory boards. His insights have been sought in meetings focused on topics such as the therapeutic positioning of diabetes medications, clinical positioning of different compositions of Vildagliptin, and the role of Remogliflozin in uncontrolled diabetes patients. He has participated in advisory meetings on the clinical implications and roles of Metformin SR+Vildagliptin, the placement of antihypertensives, and the positioning of novel SGLT2 inhibitors.

Dr. Supratik Bhattacharyya’s dedication to his field is evident through his extensive clinical practice, groundbreaking research, and commitment to patient education and advocacy. His leadership roles in various organizations and contributions to medical literature and conferences underscore his influence and expertise in endocrinology, diabetes, and obesity management. His ongoing efforts continue to impact patient care, medical research, and education, solidifying his reputation as a leading figure in his speciality.